Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Big Rock Partners Acquisition Corp (BRPA)

Big Rock Partners Acquisition Corp (BRPA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,022
  • Shares Outstanding, K 2,688
  • Annual Sales, $ 0 K
  • Annual Income, $ -430 K
  • 60-Month Beta -0.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 32.13
Trade BRPA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-6770 Blank Checks

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.55 +25.24%
on 03/25/21
57.00 -43.86%
on 03/29/21
+3.64 (+12.83%)
since 03/15/21
3-Month
25.00 +28.00%
on 03/05/21
64.20 -50.16%
on 02/02/21
+2.04 (+6.81%)
since 01/15/21
52-Week
10.50 +204.76%
on 06/30/20
76.99 -58.44%
on 12/22/20
+21.35 (+200.33%)
since 04/15/20

Most Recent Stories

More News
Big Rock Partners Acquisition Corp. Clarifies Procedure for Stockholder Conversions and Urges Stockholders To Vote "For" Extension Amendment Proposal

NEW YORK, NY / ACCESSWIRE / April 7, 2021 / Big Rock Partners Acquisition Corp. (Nasdaq:BRPA) ("Big Rock") today clarified the procedure for stockholder redemptions in connection with Big Rock's special...

BRPA : 30.51 (-4.66%)
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir

, /PRNewswire/ -- NeuroRx, Inc. reports today that Aviptadil, to be supplied by NeuroRx, has been identified by the National Institutes of Health (NIH) as one of two drugs selected for inclusion in a...

RLFTF : 0.2638 (-4.77%)
GILD : 66.60 (+1.26%)
BRPA : 30.51 (-4.66%)
NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19

, /PRNewswire/ -- NeuroRx, Inc. today reports 60-day results of the Phase /3 trial of intravenously-administered ZYESAMI™ (aviptadil acetate) for the treatment of respiratory failure in critically-ill...

BRPA : 30.51 (-4.66%)
RLFTF : 0.2638 (-4.77%)
NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure

, /PRNewswire/ -- NeuroRx, Inc. announces completion of top line data analysis of the 60-day results in its phase /3 clinical trial, conducted under FDA Fast Track Designation, of ZYESAMI™ (aviptadil...

BRPA : 30.51 (-4.66%)
Neurorx, Inc. and Big Rock Partners Acquisition Corp. Announce Committed $10 Million Pipe to Support Proposed Business Combination

WILMINGTON, DE and DELRAY BEACH, FL / ACCESSWIRE / March 15, 2021 / NeuroRx, Inc. ("NeuroRx"), a clinical stage-small molecule pharmaceutical company and Big Rock Partners Acquisition Corp. ("Big Rock")...

BRPA : 30.51 (-4.66%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, BRPA, and KTYB Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

BFTL : 3.0000 (unch)
ALXN : 164.28 (+4.28%)
BRPA : 30.51 (-4.66%)
KTYB : 36.9000 (-0.94%)
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration

and AUSTIN, Texas, /PRNewswire/ -- NeuroRx, Inc. and TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) are announcing that the companies have entered into a feasibility and material transfer agreement (Feasibility...

TFFP : 11.75 (-3.13%)
BRPA : 30.51 (-4.66%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

BFTL : 3.0000 (unch)
ALXN : 164.28 (+4.28%)
STPK : 25.54 (-2.18%)
BRPA : 30.51 (-4.66%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

BFTL : 3.0000 (unch)
ALXN : 164.28 (+4.28%)
STPK : 25.54 (-2.18%)
BRPA : 30.51 (-4.66%)
NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint

, /PRNewswire/ -- NeuroRx, Inc. announced today that the Phase /3 trial* of ZYESAMI™ (aviptadil, previously RLF-100™) for the treatment of Respiratory Failure in critically ill patients with Covid-19...

RLFTF : 0.2638 (-4.77%)
BRPA : 30.51 (-4.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Big Rock Partners is a blank check company. It formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. Big Rock Partners is based in DELRAY BEACH,...

See More

Key Turning Points

3rd Resistance Point 37.55
2nd Resistance Point 35.74
1st Resistance Point 33.87
Last Price 30.51
1st Support Level 30.19
2nd Support Level 28.38
3rd Support Level 26.51

See More

52-Week High 76.99
Fibonacci 61.8% 51.59
Fibonacci 50% 43.74
Fibonacci 38.2% 35.90
Last Price 30.51
52-Week Low 10.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar